Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1411-1420 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|January 18, 2005
Mechanism-based combination telomerase inhibition therapyJerry W Shay, Woodring E Wright
Cancer Cell|January 18, 2005
Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesisBenjamin C Ling, Jianqiang Wu, Shyra J Miller, et al.
Cancer Cell|January 18, 2005
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylaseMary A Selak, Sean M Armour, Elaine D MacKenzie, et al.
Cancer Cell|January 18, 2005
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesisYuval Shaked, Francesco Bertolini, Shan Man, et al.
Cancer Cell|May 18, 2004
Cysteine cathepsins (proteases)--on the main stage of cancer?Vito Turk, Janko Kos, Boris Turk
Cancer Cell|May 18, 2004
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expressionChristine H Chung, Joel S Parker, Gamze Karaca, et al.
Cancer Cell|May 18, 2004
Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathwayYan Wang, Ingo H Engels, Deborah A Knee, et al.
Cancer Cell|March 31, 2004
The new kid on the block(ade) of the IGF-1 receptorDerek LeRoith, Lee Helman
Cancer Cell|March 31, 2004
Selective estrogen receptor modulation: concept and consequences in cancerV Craig Jordan
Cancer Cell|March 31, 2004
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumorsConstantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
Pageof 383

Showing results (1411-1420 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|January 18, 2005
Mechanism-based combination telomerase inhibition therapyJerry W Shay, Woodring E Wright
Cancer Cell|January 18, 2005
Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesisBenjamin C Ling, Jianqiang Wu, Shyra J Miller, et al.
Cancer Cell|January 18, 2005
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylaseMary A Selak, Sean M Armour, Elaine D MacKenzie, et al.
Cancer Cell|January 18, 2005
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesisYuval Shaked, Francesco Bertolini, Shan Man, et al.
Cancer Cell|May 18, 2004
Cysteine cathepsins (proteases)--on the main stage of cancer?Vito Turk, Janko Kos, Boris Turk
Cancer Cell|May 18, 2004
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expressionChristine H Chung, Joel S Parker, Gamze Karaca, et al.
Cancer Cell|May 18, 2004
Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathwayYan Wang, Ingo H Engels, Deborah A Knee, et al.
Cancer Cell|March 31, 2004
The new kid on the block(ade) of the IGF-1 receptorDerek LeRoith, Lee Helman
Cancer Cell|March 31, 2004
Selective estrogen receptor modulation: concept and consequences in cancerV Craig Jordan
Cancer Cell|March 31, 2004
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumorsConstantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
Pageof 383